0 CHECKOUT

PRODUCT FILTERS

REGION

23
4
3
3
3

COUNTRY

PRICE

2
46
84
164

PUBLISHED

58
65
86
164

PRODUCT TYPE

162
2

Lymphoma

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances,...

Published:  June 2014
Price:  From

Global Hodgkins Lymphoma Therapeutics Market 2014-2018

About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing...

Published:  August 2014
Price:  From

Mantle Cell Lymphoma-API Insights

Summary Mantle Cell Lymphoma-API Insights, 2015 report provides Mantle Cell Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives...

Published:  February 2016
Price:  From

Burkitt Lymphoma-API Insights

Summary Burkitt Lymphoma-API Insights, 2015 report provides Burkitt Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear...

Published:  February 2016
Price:  From

Acute Lymphoblastic Lymphoma-API Insights

Summary Acute Lymphoblastic Lymphoma-API Insights, 2015 report provides Acute Lymphoblastic Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location....

Published:  February 2016
Price:  From

Velcade-API Insights

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large...

Published:  February 2016
Price:  From

Treanda-API Insights

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large...

Published:  February 2016
Price:  From

Non-Hodgkin Lymphoma-API Insights

Summary Non-Hodgkin Lymphoma-API Insights, 2015 report provides Non-Hodgkin Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives...

Published:  February 2016
Price:  From

Hodgkin Lymphoma-API Insights

Summary Hodgkin Lymphoma-API Insights, 2015 report provides Hodgkin Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear...

Published:  February 2016
Price:  From

Lymphoma-API Insights

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large...

Published:  February 2016
Price:  From

Velcade -Drug Insights, 2016

Drug Report, “Velcade- Drug Insights, 2016” highlights the Velcade marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment...

Published:  February 2016
Price:  From

Targretin Capsules -Drug Insights, 2016

Drug Report, “Targretin Capsules- Drug Insights, 2016” highlights the Targretin Capsules marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers...

Published:  February 2016
Price:  From

T-Cell Lymphomas-Pipeline Insights, 2016

“ T-Cell Lymphomas-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the T-Cell Lymphomas. The report covers the product profiles in...

Published:  February 2016
Price:  From

Rituxan -Drug Insights, 2016

Drug Report, “Rituxan- Drug Insights, 2016” highlights the Rituxan marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment...

Published:  February 2016
Price:  From

Indolent Lymphoma-Pipeline Insights, 2016

“ Indolent Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Indolent Lymphoma. The report covers the product profiles...

Published:  February 2016
Price:  From

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  February 2016
Price:  From

Lymphoblastic Lymphoma-Pipeline Insights, 2016

“ Lymphoblastic Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Lymphoblastic Lymphoma. The report covers the product...

Published:  February 2016
Price:  From

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016

“ Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Anaplastic Large Cell Lymphoma (ALCL)....

Published:  February 2016
Price:  From

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016

“ B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the B-Cell Non-Hodgkin Lymphoma. The report covers the...

Published:  February 2016
Price:  From

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016

“ Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Peripheral T-Cell Lymphomas (PTCL). The report...

Published:  February 2016
Price:  From
Loading Indicator

Our Clients